Aclarion, Inc. (ACON) vs Renalytix plc - Sponsored ADR (RNLXY)

Aclarion, Inc. and Renalytix plc - Sponsored ADR are both Health Information Services companies. Renalytix plc - Sponsored ADR is the larger, with a market value of $17.2M against $7.6M — 2.3× the size. Aclarion, Inc. grew revenue faster over the last twelve months: 33.1% against −18.3%. Renalytix plc - Sponsored ADR has the higher net margin (−1,695.9% vs −10,987.6%) and the higher return on invested capital (0.00% vs −876.8%). Across the 16 metrics below, Renalytix plc - Sponsored ADR leads on 9 and Aclarion, Inc. on 7.

Valuation

Metric ACON RNLXY Health Information Services median
P/E n/m n/m 39.52
P/S 79.13 3.58 2.65
P/B 0.39 n/m 2.32
Price to free cash flow n/m n/m 16.77
EV/EBITDA 0.95 n/m 12.35
EV/Sales (107.04) 2.95 3.06
Earnings yield (275.09%) (446.98%) (1.68%)
Free cash flow yield (124.73%) (273.01%) 0.54%

Profitability

Metric ACON RNLXY Health Information Services median
Gross margin 21.86% 14.52% 63.38%
Operating margin (11,601.67%) (1,087.73%) (8.35%)
Net margin (10,987.57%) (1,695.90%) (14.70%)
Free cash flow margin (9,870.13%) 0.00% 0.58%
Return on equity (58.97%) 0.00% (6.82%)
Return on assets (56.09%) 0.00% (6.02%)
Return on invested capital (876.79%) 0.00% 0.00%

Growth

Metric ACON RNLXY Health Information Services median
Revenue growth (TTM) 33.07% (18.32%) 8.62%
EPS growth (last fiscal year) 99.82% 82.14% —
Revenue growth, 5-year CAGR 9.22% — 12.36%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACON RNLXY Health Information Services median
Debt to equity 0.00 (5.99) 0.01
Current ratio 16.20 2.43 2.37
Net debt to EBITDA 1.76 (0.26) 0.50

Dividend

Metric ACON RNLXY Health Information Services median
Dividend yield — — 0.85%
Payout ratio 0.00 0.00 0.00

Size

Metric ACON RNLXY Health Information Services median
Market cap 7.58m 17.18m 352.86m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack